EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care

Rianne Carragher, Kevin Woo, Mary Smith, Mona Sawhney

Canadian Nurse Practitioner Journal · 2025

DOI: 10.28984/cnpj.v5i2.475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Nurse Practitioner Journal, 2025. Verfasst von Rianne Carragher und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study was to explore most responsible providers’ acceptance and perceptions of prescribing nabilone and authorizing THC/CBD oil for the management of behavioural and psychological symptoms of dementia (BPSD) in people living with dementia.

Methods

A cross-sectional survey was sent to 9 most responsible providers (MRP) of residents with dementia residing in long-term care settings. The participant sample included 8 nurse practitioners and 1 physician.

Results

Data were analysed using survey outcome categories: MRP acceptance of nabilone for BPSD; MRP perception of nabilone; MRP acceptance of THC/CBD oil for BPSD; and MRP perceptions of THC/CBD oil. Participants considered BPSD to be managed somewhat well (77.8%) or very well (22.2%) in their resident population. More than half (66.7%) of participants have previously prescribed nabilone to manage BPSD, and 55.6% have trialed THC/CBD oil. Only 12.5% reported they were prepared to answer a resident or family member’s questions regarding nabilone “a great deal” (0% for THC/CBD oil), and 37.5% reported “quite a bit”. However, participants indicated they were less prepared to answer questions regarding THC/CBD oil. The participants felt that nabilone prescription for BPSD could “somewhat improve” quality-of-life indicators including physical functioning (71.4%); energy levels (57.1%); mood (100%); enjoyment of life (100%); social engagement (85.7%); ability to perform activities of daily living (57.1%); and sense of hope (83.3%).

Conclusion

Participants believed that nabilone and THC/CBD could improve quality-of-life outcomes in their residents living with dementia, including physical functioning and mood outcomes. Most participants believed that nabilone and THC/CBD oil could effectively treat BPSD, however, some participants reported a lack of confidence in answering resident or family questions about cannabinoid treatments. Further research is required to understand MRP acceptance and perceptions of specific cannabinoid products for BPSD in long-term care settings.

Zitieren

APA

Carragher, R., Woo, K., Smith, M., & Sawhney, M. (2025). Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care. Canadian Nurse Practitioner Journal. https://doi.org/10.28984/cnpj.v5i2.475

Vancouver

Carragher R, Woo K, Smith M, Sawhney M. Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care. Canadian Nurse Practitioner Journal. 2025. doi:10.28984/cnpj.v5i2.475

BibTeX
@article{Carragher2025,
  author = {Carragher, Rianne and Woo, Kevin and Smith, Mary and Sawhney, Mona},
  title = {Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care},
  journal = {Canadian Nurse Practitioner Journal},
  year = {2025},
  doi = {10.28984/cnpj.v5i2.475}
}
Kostenlos starten →